Connect with us

Technology

Sleep Apnea Devices Market worth $9.3 billion by 2029 driven by Rising Technological Advancements | MarketsandMarkets™

Published

on

CHICAGO, July 23, 2024 /PRNewswire/ — The global Sleep Apnea Devices Market is expected to grow from USD 6.5 billion in 2024 to USD 9.3 billion by 2029, at a CAGR of 7.3%. The sleep apnea devices market is experiencing significant growth opportunities driven by the adoption of telemedicine, mHealth, and artificial intelligence for treatment and diagnosis, along with the expansion of leading players into emerging markets like India, Australia, UAE, and Saudi Arabia. Increased investments and funding are fostering innovations in CPAP devices and diagnostics, improving patient compliance and accessibility to advanced solutions. However, insufficient awareness of sleep apnea and poor adherence to CPAP devices pose challenges to market expansion. The rising popularity of cost-effective home sleep apnea tests and next-generation sleep-sensing technologies offers further growth potential. In 2023, the PAP devices segment led the therapeutic devices market, while home care settings dominated the end-user segment. The Asia Pacific region observed the highest growth rate due to a large patient pool with comorbidities and an increasing number of sleep clinics. Key market players include ResMed, Koninklijke Philips N.V., and Fisher & Paykel Healthcare Limited, noted for their extensive product portfolios and wide geographic presence.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=719

Browse in-depth TOC on “Sleep Apnea Devices Market”

483 – Table
50 – Figures
366 – Pages

RESMED (US): Market Leader in Sleep Apnea Devices

ResMed (US) led the sleep apnea devices market in 2023, renowned for its innovative and advanced therapeutic and diagnostic devices. The company’s focus on healthcare technology expertise enables it to produce accurate and efficient sleep apnea devices, securing a significant market share. By expanding its product offerings, including PAP devices and facial interfaces, ResMed has maintained its market leadership.

KONINKLIJKE PHILIPS N.V. (Netherlands): Major Player in Sleep Apnea Devices

In 2023, Koninklijke Philips N.V. (Netherlands) held the second-largest share of the sleep apnea devices market. Known for its innovative and user-friendly health monitoring devices, Philips is expanding its global presence through strategic partnerships and acquisitions. These efforts increase accessibility and awareness of sleep apnea solutions in emerging and developing markets.

FISHER & PAYKEL HEALTHCARE LIMITED (New Zealand): Innovator in Patient Comfort

Fisher & Paykel Healthcare Limited (New Zealand) secured the third-largest share of the sleep apnea devices market in 2023. The company’s Hospitals and Homecare segments drive sales of sleep apnea devices. Focused on product development, Fisher & Paykel emphasizes advanced humidification and mask technologies to enhance patient comfort and therapeutic effectiveness, thereby expanding its market presence.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=719

Product Segmentation: Therapeutic Devices Lead the Sleep Apnea Devices Market

The sleep apnea devices market is segmented by product into therapeutic devices and diagnostic devices. In 2023, the therapeutic devices segment accounted for the largest share, driven by the launch of advanced and non-invasive therapeutic sleep apnea devices. Therapeutic devices include positive airway pressure (PAP) devices, facial interfaces (masks), accessories, oral appliances, and other therapeutic devices, all contributing to the segment’s growth.

End User Segmentation: Home Care Settings Dominate

The sleep apnea devices market is categorized by end users into sleep laboratories, clinics, hospitals, and home care settings/individuals. In 2023, home care settings/individuals held the largest market share. Devices used in home care settings, such as PAP devices, nasal masks, oral appliances, ambulatory PSG, oxygen concentrators, and pulse oximeters, are preferred for their ease of use and patient preference for home sleep testing over testing in sleep laboratories, clinics, and hospitals.

Age Group Segmentation: 40-60 Years Lead

The sleep apnea devices market is divided by age group into below 40 years, 40–60 years, and above 60 years. In 2023, the 40-60 years segment accounted for the largest share. High awareness and diagnosis rates, along with the rise in comorbidities such as hypertension and diabetes in this age group, contribute to its dominance. This age group is more adaptable to sleep apnea therapeutic technology for health management compared to other age groups.

Gender Segmentation: Male Patients Lead

The sleep apnea devices market is segmented by gender into male and female patients. In 2023, male patients dominated the market, driven by the higher prevalence of hypertension, cardiovascular disease, stroke, and daytime sleepiness among men compared to women. This higher prevalence results in increased diagnosis and treatment rates in the male population.

Regional Insights: Asia Pacific Offers Significant Growth Opportunities

The global sleep apnea devices market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries. The Asia Pacific region is expected to offer significant growth opportunities for sleep apnea device manufacturers over the next 5-10 years. This growth is driven by increasing cases of comorbidities such as diabetes and cardiovascular diseases, as well as growing awareness of sleep apnea, which leads to higher diagnosis rates.

For more information, inquire now! Inquire Now

Related Reports:

Medical Equipment Maintenance Market

Respiratory Care Devices Market

Respiratory Diagnostics Market

Ultrasound Market

Diagnostic Imaging Market

Get access to the latest updates on Sleep Apea Devices Companies and Sleep Apnea Devices Market Share

About MarketsandMarkets™:

MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/

Logo: https://mma.prnewswire.com/media/1951202/4609423/MarketsandMarkets.jpg

 

View original content:https://www.prnewswire.co.uk/news-releases/sleep-apnea-devices-market-worth-9-3-billion-by-2029-driven-by-rising-technological-advancements–marketsandmarkets-302203697.html

Continue Reading

Technology

Agenda for the 4th Hong Kong Clinical-driven Robotics and Embodied AI Technology (CREATE) Symposium Officially Released

Published

on

By

Leading Experts from Medicine, Research, Industry and Investment Revealed

HONG KONG, Sept. 11, 2026 /PRNewswire/ — Scheduled for September 22–23, 2026, the 4th Hong Kong Clinical-driven Robotics and Embodied AI Technology (CREATE) Symposium will be held at the Charles K. Kao Auditorium in Hong Kong Science Park. The Centre for Artificial Intelligence and Robotics (CAIR), Hong Kong Institute of Science & Innovation, Chinese Academy of Sciences (CAS), organizes the event, with co-organization by the Hong Kong Science and Technology Parks Corporation (HKSTP).

The CREATE Symposium is dedicated to building a platform for in-depth dialogue between clinical medicine and cutting-edge technology. Having been held successfully for multiple editions, it has become a flagship international symposium on embodied intelligence in healthcare. This year’s event will focus on the practical clinical needs of more than ten specialties, including neurology, neurosurgery, respiratory intervention, otolaryngology, ultrasound imaging, and sleep medicine. It will bring together world-leading academicians, hospital directors, department leaders, and innovative scholars at the intersection of medicine and engineering to explore clinical applications and translation pathways of AI and robotics technologies, accelerating innovation and industrialization in global healthcare technology.

Symposium Highlights

This year’s symposium features a special “Hospital Presidents’ Roundtable” session. Eight hospital leaders from the Greater Bay Area will engage in in-depth discussions on integrating medicine and engineering, smart hospital development, and practical applications of medical AI.

The distinguished panel includes:

Linbo CAI, President of Guangdong 999 Brain Hospital, Chief Physician, and Doctoral Supervisor at Jinan University.

Kenneth Man-Chee CHEUNG, President and Hospital Chief Executive of The University of Hong Kong – Shenzhen Hospital, The Jessie Ho Professor in Spine Surgery and Chair Professor, Department of Orthopedics and Traumatology, HKU.

Kin-lai CHUNG, CEO of The Chinese University of Hong Kong (CUHK) Medical Centre.

Xiquan HU, Director, Management Committee of Lingnan Hospital; Director and Chief Physician, Department of Rehabilitation Medicine, The Third Affiliated Hospital, Sun Yat-sen University; President-Elect, Chinese Society of Physical Medicine and Rehabilitation, Chinese Medical Association.

Lijian JIN, Dean of Faculty of Dentistry, Modern Dental Group Professor in Clinical Dental Science, HKU.

Wing-yee SO, Hospital Chief Executive of North District Hospital, Hospital Authority.

Kenneth Hing Lim TSANG, Regional CEO of IHH Healthcare North Asia, CEO of Gleneagles Hospital Hong Kong.

Yi XIONG, Executive Director of Shenzhen Luohu District People’s Hospital.

The symposium will also launch CARES 4.0, a multi-modal medical AI large model and intelligent agent system for healthcare scenarios. Concurrently, a dedicated MedTech innovation exhibition will showcase cutting-edge medical hardware, AI algorithms, and other innovative achievements, demonstrating the latest capabilities in embodied intelligent healthcare.

As a co-organizer of this year’s symposium, HKSTP will host a special session titled “Empowering Founders, Enabling Growth: HKSTP’s Entrepreneurship Journey from Idea to Commercialization”. The session will introduce HKSTP’s life and health technology ecosystem and startup community, share The Road to Commercialization: Insights and Success Stories from HKSTP Startups, and feature the Roundtable Discussion: Empowering Value Creation and Growth through Strategic Partnerships.

Notably, the CREATE Symposium will debut a new “Roadshow Session” on September 23. The session will connect top-tier investment institutions with innovative companies. Participating companies will showcase products and technologies while receiving professional feedback from leading investors.

Investors from renowned institutions including Guangyuan Investment, Jiuguang Capital, Allwinner Technology, Yuexiu Group, Yanghe Investment, CICC Capital, Jianyuan Tianhua etc. have been invited to serve as judges. Invitations are also being extended to institutions such as Shenzhen Angel Fund of Funds, CCB International etc.

This year’s symposium will fully integrate MEDLing, CAIR’s proprietary intelligent conference assistant. The system has been customized and optimized for medical terminology, providing real-time speech transcription in Mandarin, English, and Cantonese, as well as high-precision transcript recording and simultaneous translation throughout the event. This will enable attendees from diverse fields and countries to communicate seamlessly and enjoy an enhanced conference experience.

Conference Information

Date: September 22–23, 2026 (Tuesday–Wednesday)
Venue: Charles K. Kao Auditorium, Hong Kong Science Park
Event Details and Latest Schedule: https://www.cair-cas.org.hk/article/662
Registration Link: https://forms.office.com/r/ePnu6HMySU?origin=lprLink

This year’s symposium features a dedicated healthcare technology exhibition area in the Atrium Link of Hong Kong Science Park. During the event, multiple guided tours will be organized to facilitate exchanges among attendees, academic experts, and industry representatives, fostering in-depth cross-sector collaboration.

Currently, only a limited number of booths remain available in the corporate exhibition area. Interested companies are invited to review partnership options

View original content:https://www.prnewswire.com/apac/news-releases/agenda-for-the-4th-hong-kong-clinical-driven-robotics-and-embodied-ai-technology-create-symposium-officially-released-302876370.html

SOURCE Centre for Artificial Intelligence and Robotics (CAIR), Hong Kong Institute of Science & Innovation, Chinese Academy of Sciences

Continue Reading

Technology

Scholarship America Marks 25th Anniversary of 9/11 by Honoring Its Support for the Families of Freedom Scholarship Fund

Published

on

By

NEW YORK, Sept. 11, 2026 /PRNewswire/ — Scholarship America today marks the 25th anniversary of the Families of Freedom Scholarship Fund, which it established and has administered since the fund’s founding in the direct aftermath of the September 11th attacks.

On September 11, 2001, the unthinkable happened, and the nation was forever changed. Thousands of children, including those of Ground Zero first responders, lost a parent or watched one become permanently disabled. In response, Scholarship America helped establish the Families of Freedom Fund to protect the dreams of these students, which it has proudly administered for more than two decades.

In the years since, the Fund’s scope has expanded to include the children of rescue and rebuilding workers who developed long-term and chronic illnesses tied to their service, nearly doubling the number of students eligible for support. Meeting that growing need has required an equally significant response: more than 20,000 individuals, corporations, foundations, and organizations – including longtime supporters Citi and Strada Education Foundation – have contributed to the Fund, helping award $193 million to 3,877 students who lost a parent or had one permanently disabled as a result of the September 11th attacks and the recovery efforts that followed.

“From the moment the horrific attacks unfolded, we knew the impact would echo across generations,” said Brandee McHale, Head of Community Investing and Development at Citi and President of the Citi Foundation. “We are proud of the work we did with organizations across the country to create this Fund, making a lasting commitment to support the educational needs of the children of victims.”

The Fund’s commitment will carry through 2030, when its youngest beneficiaries complete their undergraduate education.

“Twenty-five years later, we still remember how this Fund began—born out of one of the worst days in our nation’s history in an effort to ensure that these victims’ children wouldn’t lose their futures along with their loved ones,” said Mike Nylund, President and CEO of Scholarship America. “A promise was made to these students, and Scholarship America has been honored to help keep it for the past twenty-five years. Watching them graduate, build careers, and give back to their own communities has been one of the great privileges of this organization’s history.  On behalf of every student this Fund has supported, I am incredibly grateful for the generosity that made it possible.”

About Scholarship America

Since 1958, Scholarship America has been committed to breaking down financial barriers to higher education, turning the generosity of donors into life-changing opportunities for students across the country. To date, the organization has distributed more than $6 billion in scholarships to over 3.5 million students, making it the nation’s leading nonprofit scholarship administrator. Scholarship America also partners with individuals, foundations, small businesses, and nearly half of today’s Fortune 500 companies to deliver end-to-end scholarship program management for students pursuing degrees and certifications at technical, vocational, and two- and four-year colleges and universities.

Contacts:

Claire Berge Schmidt
Scholarship America
cbergeschmidt@scholarshipamerica.org

Logan Flynn
Hiltzik Strategies
lflynn@hstrategies.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/scholarship-america-marks-25th-anniversary-of-911-by-honoring-its-support-for-the-families-of-freedom-scholarship-fund-302875885.html

SOURCE Scholarship America

Continue Reading

Technology

The 26th CIFIT Opens in Xiamen, Merchants from 129 Countries and Regions Seek Business Opportunities

Published

on

By

XIAMEN, China, Sept. 11, 2026 /PRNewswire/ — A report from IQINGDAO:

The 26th China International Fair for Investment and Trade (CIFIT) opened in Xiamen on September 8. More than 1,200 government agencies and business delegations from 129 countries and regions as well as 30 international organizations gathered at the event to explore opportunities for two‑way investment and cooperation.

As a landmark platform for “Invest in China”, this year’s CIFIT revolves around three major sections: “Invest in China”, “Chinese Investment” and “International Investment”. For the first time, it features Finland and Saudi Arabia as dual Guest Countries of Honor, and Guangdong and Qinghai as dual Guest Provinces of Honor.

Both the exhibition area and the number of exhibitors in the financial zone have doubled at this edition. A special zone for the Cross‑border Interbank Payment System (CIPS) makes its debut at CIFIT. A new special zone for new quality productive forces has been set up, focusing on cutting‑edge sectors including artificial intelligence and low‑altitude economy.

Over 40 key investment‑promotion events will be held during the fair, alongside nearly 100 supporting activities such as capital matchmaking and special‑topic roadshows. The Online CIFIT platform pools resources including investment‑attraction projects, corporate financing and industrial funds. Empowered by digital technologies, it enables easier project sourcing and more efficient capital matching.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/the-26th-cifit-opens-in-xiamen-merchants-from-129-countries-and-regions-seek-business-opportunities-302876390.html

SOURCE Iqingdao

Continue Reading

Trending